Ketamine and the core symptoms of autism

Theodore A. Kastner, Kevin Walsh, Lisa H. Shulman, Farah Alam, Samuel Flood

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Autism or autism spectrum disorder (ASD) is a behavioral syndrome characterized by (a) persistent deficits in social communication and social interaction across multiple contexts and (b) restricted, repetitive patterns of behavior, interests or activities. However, the etiology of autism in most cases remains unknown. Ketamine, an N-Methyl-D-aspartate (NMDA) blocker, has been purported by some as a possible treatment for autism. This conclusion is premature. Here, we present a single case study in which a patient with a severe intellectual disability was said to have demonstrated a dramatic, albeit short-lived, remission of the core symptoms of autism following adventitious treatment with ketamine. Although this anecdote is encouraging, we argue that further analysis of ketamine as a treatment for autism is needed.

Original languageEnglish (US)
Pages (from-to)121-123
Number of pages3
JournalInternational Journal on Disability and Human Development
Volume15
Issue number1
DOIs
StatePublished - Feb 1 2016

Fingerprint

Ketamine
Autistic Disorder
Anecdotes
N-Methylaspartate
Interpersonal Relations
Intellectual Disability
Therapeutics
Communication

Keywords

  • autism
  • behavior
  • ketamine
  • psychopharmacology
  • secretin

ASJC Scopus subject areas

  • Rehabilitation
  • Geriatrics and Gerontology
  • Advanced and Specialized Nursing
  • Psychiatry and Mental health
  • Sensory Systems
  • Speech and Hearing

Cite this

Ketamine and the core symptoms of autism. / Kastner, Theodore A.; Walsh, Kevin; Shulman, Lisa H.; Alam, Farah; Flood, Samuel.

In: International Journal on Disability and Human Development, Vol. 15, No. 1, 01.02.2016, p. 121-123.

Research output: Contribution to journalArticle

Kastner, Theodore A. ; Walsh, Kevin ; Shulman, Lisa H. ; Alam, Farah ; Flood, Samuel. / Ketamine and the core symptoms of autism. In: International Journal on Disability and Human Development. 2016 ; Vol. 15, No. 1. pp. 121-123.
@article{a7737572f85a4027a954754c05a9a920,
title = "Ketamine and the core symptoms of autism",
abstract = "Autism or autism spectrum disorder (ASD) is a behavioral syndrome characterized by (a) persistent deficits in social communication and social interaction across multiple contexts and (b) restricted, repetitive patterns of behavior, interests or activities. However, the etiology of autism in most cases remains unknown. Ketamine, an N-Methyl-D-aspartate (NMDA) blocker, has been purported by some as a possible treatment for autism. This conclusion is premature. Here, we present a single case study in which a patient with a severe intellectual disability was said to have demonstrated a dramatic, albeit short-lived, remission of the core symptoms of autism following adventitious treatment with ketamine. Although this anecdote is encouraging, we argue that further analysis of ketamine as a treatment for autism is needed.",
keywords = "autism, behavior, ketamine, psychopharmacology, secretin",
author = "Kastner, {Theodore A.} and Kevin Walsh and Shulman, {Lisa H.} and Farah Alam and Samuel Flood",
year = "2016",
month = "2",
day = "1",
doi = "10.1515/ijdhd-2015-0003",
language = "English (US)",
volume = "15",
pages = "121--123",
journal = "International Journal on Disability and Human Development",
issn = "2191-1231",
publisher = "Freund Publishing House Ltd",
number = "1",

}

TY - JOUR

T1 - Ketamine and the core symptoms of autism

AU - Kastner, Theodore A.

AU - Walsh, Kevin

AU - Shulman, Lisa H.

AU - Alam, Farah

AU - Flood, Samuel

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Autism or autism spectrum disorder (ASD) is a behavioral syndrome characterized by (a) persistent deficits in social communication and social interaction across multiple contexts and (b) restricted, repetitive patterns of behavior, interests or activities. However, the etiology of autism in most cases remains unknown. Ketamine, an N-Methyl-D-aspartate (NMDA) blocker, has been purported by some as a possible treatment for autism. This conclusion is premature. Here, we present a single case study in which a patient with a severe intellectual disability was said to have demonstrated a dramatic, albeit short-lived, remission of the core symptoms of autism following adventitious treatment with ketamine. Although this anecdote is encouraging, we argue that further analysis of ketamine as a treatment for autism is needed.

AB - Autism or autism spectrum disorder (ASD) is a behavioral syndrome characterized by (a) persistent deficits in social communication and social interaction across multiple contexts and (b) restricted, repetitive patterns of behavior, interests or activities. However, the etiology of autism in most cases remains unknown. Ketamine, an N-Methyl-D-aspartate (NMDA) blocker, has been purported by some as a possible treatment for autism. This conclusion is premature. Here, we present a single case study in which a patient with a severe intellectual disability was said to have demonstrated a dramatic, albeit short-lived, remission of the core symptoms of autism following adventitious treatment with ketamine. Although this anecdote is encouraging, we argue that further analysis of ketamine as a treatment for autism is needed.

KW - autism

KW - behavior

KW - ketamine

KW - psychopharmacology

KW - secretin

UR - http://www.scopus.com/inward/record.url?scp=84958741670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958741670&partnerID=8YFLogxK

U2 - 10.1515/ijdhd-2015-0003

DO - 10.1515/ijdhd-2015-0003

M3 - Article

AN - SCOPUS:84958741670

VL - 15

SP - 121

EP - 123

JO - International Journal on Disability and Human Development

JF - International Journal on Disability and Human Development

SN - 2191-1231

IS - 1

ER -